Madison Group Ventures Inc

The Lieber Institute for Brain Development in Baltimore, MD, is dedicated to unlocking the mysteries of the brain through innovative research focused on various neurodevelopmental and psychiatric disorders, including schizophrenia, autism, and mood disorders. Their mission encompasses investigating the genetic, epigenetic, and environmental factors influencing brain health, with the ultimate goal of improving diagnosis and treatment while addressing health disparities in marginalized communities. Leveraging a diverse community of scientists, the institute also emphasizes the importance of early childhood development and the impact of environmental stressors on mental health. Through interdisciplinary approaches, they aim to advance understanding and treatment of addiction, suicide, and other critical issues affecting mental health in society. Generated from the website

Elixirgen Scientific, Inc. is a biotechnology company based in Baltimore, MD, specializing in innovative research and development in the field of regenerative medicine. With a focus on cutting-edge technologies, Elixirgen Scientific, Inc. aims to advance scientific knowledge and contribute to the development of new therapeutic approaches for various medical conditions. Generated from their business information

Glyscend Inc., located in Baltimore, MD, is pioneering innovative treatments for Type 2 Diabetes and obesity through a novel class of gut-targeted polymer therapies. Their dynamic barrier approach aims to deliver the benefits of metabolic surgery without the invasiveness, utilizing orally administered drugs that replicate the physiological effects of bariatric procedures. With a team experienced in gastroenterology, metabolism, polymer chemistry, and drug development, Glyscend has contributed to over 25 FDA-approved products, including several first-in-class therapies. Their latest advancements include the enrollment of patients in clinical trials for their first-in-class oral polymeric drug candidate, GLY-200, aimed at treating metabolic diseases. Generated from the website